Improving Aspirin Prescription Rates in Outpatient Clinic
Key facts
- Who runs it
- Cairo University
- Where
- Kuwait1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 300 people enrolled
- Started
- 1 Nov 2024
- Ended
- 30 Apr 2025
- Type of study
- Observational
- Treatments tested
- Aspirin prescription on outpatient basis
- Record updated
- 10 July 2025
- Why it stopped
- Could not obtain ethical approval yet
Who can take part
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Women at high risk are those with any of the following:
- hypertensive disease during a previous pregnancy
- chronic kidney disease
- autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome
- type 1 or type 2 diabetes
- chronic hypertension; Women with more than one moderate risk factor, such as are:
- nulliparity
- age 40 years or older
- pregnancy interval of more than 10 years
- body mass index (BMI) of 35 kg/m2 or more at first visit
- family history of pre-eclampsia
- multi-fetal pregnancy
Who cannot take part
- None. All eligible candidates will be included
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies.
Read full original descriptionShow less
Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients.
A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.
The group in the trial
- Obstetric population candidate for aspirin prescription
Moderate- and high-risk obstetric population
Treatment: Aspirin prescription on outpatient basis
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Aspirin Prescription For Moderate- and High-Risk Obstetric Population in Outpatient Clnic; A Quality Improvement Project.
- Record updated
- 10 July 2025